Biologics Market, By Product (Monoclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cellular-based Biologics, Gene-based Biologics, and Others), By Drug Classification (Branded Drugs and Generic Drugs), By Route of Administration (Oral, Parenter

Biologics Market, By Product (Monoclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cellular-based Biologics, Gene-based Biologics, and Others), By Drug Classification (Branded Drugs and Generic Drugs), By Route of Administration (Oral, Parenteral, and Other Routes), By Mode of Purchase (Prescription-Based Drugs and Over-The-Counter Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies),By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa).


Biologics refers to medicines created from living organisms that are used to prevent, treat, and cure human diseases. These include vaccines, blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Increasing prevalence of chronic diseases worldwide coupled with rising elderly population prone to various illnesses can boost demand for biologics. Rapid innovations and advancements in biotechnology have enabled development of novel biologic agents with improved safety, efficacy and specificity of action. This has expanded treatment options for several life-threatening conditions such as cancer, rheumatic disorders, and autoimmune diseases. Growing regulatory approvals and commercialization of biologics can drive the market growth.

Market Dynamics

Global biologics market growth is driven by growing prevalence of chronic diseases worldwide such as diabetes, cancer, cardiovascular diseases along with rising healthcare expenditure on biopharmaceutical R&D. Increasing demand for protein-based drugs, rapid approvals of advanced biologics and strong pipeline of novel biologic candidates can also drive the market growth. Constant technological advancements in bioprocessing and quality analytics enables development of high-yield production platforms conducive for cost-effective manufacturing of biologics at commercial scale. However, factors such as high capital investment needs for setting up bio-manufacturing facilities, stringent regulatory norms, and complexity of biological molecules poses challenges in biosimilar development. Emerging markets across developing regions such as Asia Pacific and Latin America offer lucrative opportunities for stakeholders to tap into new geographic territories and offset restraint impact.

Key Features of the Study
  • This report provides in-depth analysis of the global biologics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global biologics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., AbbVie Inc., Amgen Inc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Gilead Sciences, Inc., Novartis AG, Bristol-Myers Squibb Company, Regeneron Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Biogen Inc., Eli Lilly and Company, and Celltrion Healthcare Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global biologics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biologics market
Market Segmentation
  • By Product Insights (Revenue, USD Mn, 2019 - 2031)
  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Hormones/Proteins
  • Cellular-based Biologics
  • Gene-based Biologics
  • Others
  • By Drug Classification Insights (Revenue, USD Mn, 2019 - 2031)
  • Branded Drugs
  • Generic Drugs
  • By Route of Administration Insights (Revenue, USD Mn, 2019 - 2031)
  • Oral
  • Parenteral
  • Other Routes
  • By Mode of Purchase Insights (Revenue, USD Mn, 2019 - 2031)
  • Prescription-Based Drugs
  • Over-The-Counter Drugs
  • By Distribution Channel Insights (Revenue, USD Mn, 2019 - 2031)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Insights (Revenue, USD Mn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Key Players Insights
  • F. Hoffmann-La Roche Ltd.
  • AbbVie Inc.
  • Amgen Inc.
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Gilead Sciences, Inc.
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Regeneron Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company Limited
  • Biogen Inc.
  • Eli Lilly and Company
  • Celltrion Healthcare Co., Ltd.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Biologics Market, By Product
Global Biologics Market, By Drug Classification
Global Biologics Market, By Route of Administration
Global Biologics Market, By Mode of Purchase
Global Biologics Market, By Distribution Channel
Global Biologics Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
Industry Trends
4. Global Biologics Market, By Product, 2019-2031, (USD Mn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Monoclonal Antibodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Recombinant Hormones/Proteins
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Cellular-based Biologics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Gene-based Biologics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
5. Global Biologics Market, By Drug Classification, 2019-2031, (USD Mn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Branded Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Generic Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
6. Global Biologics Market, By Route of Administration, 2019-2031, (USD Mn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Parenteral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Other Routes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
7. Global Biologics Market, By Mode of Purchase, 2019-2031, (USD Mn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Prescription-Based Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Over-The-Counter Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
8. Global Biologics Market, By Distribution Channel, 2019-2031, (USD Mn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
9. Global Biologics Market, By Region, 2019 - 2031, (USD Mn)
Introduction
Market Share (%) Analysis, 2024,2027 & 2031, (USD Mn)
Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Mn)
Regional Trends
North America
Introduction
Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Drug Classification, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Mode of Purchase, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Drug Classification, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Mode of Purchase, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Drug Classification, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Mode of Purchase, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Drug Classification, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Mode of Purchase, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Drug Classification, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Mode of Purchase, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Drug Classification, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Mode of Purchase, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Mn)
South Africa
North Africa
Central Africa
10. Competitive Landscape
Hoffmann-La Roche Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
AbbVie Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Amgen Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Johnson & Johnson Services, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Merck & Co., Inc.
Pfizer Inc.
Sanofi S.A.
Gilead Sciences, Inc.
Novartis AG
Bristol-Myers Squibb Company
Regeneron Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited
Biogen Inc.
Eli Lilly and Company
Celltrion Healthcare Co., Ltd.
11. References and Research Methodology
References
Research Methodology
About us
*Browse 32 market data tables and 28 figures on ‘Biologics Market' - Global forecast to 2031

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings